185 related articles for article (PubMed ID: 37382008)
1. [Role of podocyte injury signaling pathway in steroid-resistant nephrotic syndrome and research progress in traditional Chinese medicine intervention].
Yu WX; Yan W; Dai EL; Tian WX; Dang WJ
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(12):3246-3254. PubMed ID: 37382008
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A attenuates steroid resistant nephrotic syndrome through suPAR/uPAR-αvβ3 signaling Inhibition.
Li X; Qi D; Wang MY; Ji K; Xie QL; Wang Y; Du SH; Fan HY
J Ethnopharmacol; 2021 Oct; 279():114351. PubMed ID: 34157324
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism.
Lin L; Ye Y; Fu H; Gu W; Zhao M; Sun J; Cao Z; Huang G; Xie Y; Liu F; Li L; Li Q; Mao J; Hu L
Cell Commun Signal; 2023 Nov; 21(1):324. PubMed ID: 37957688
[TBL] [Abstract][Full Text] [Related]
4. Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.
Kitzler TM; Kachurina N; Bitzan MM; Torban E; Goodyer PR
Pediatr Nephrol; 2018 Oct; 33(10):1741-1750. PubMed ID: 29982877
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of cultured podocytes exposed to nephrotic plasma reveals intrinsic molecular signatures of nephrotic syndrome.
Panigrahi S; Pardeshi VC; Chandrasekaran K; Neelakandan K; Ps H; Vasudevan A
Clin Exp Pediatr; 2021 Jul; 64(7):355-363. PubMed ID: 33147911
[TBL] [Abstract][Full Text] [Related]
6. [Regulation of myocardial ischemia reperfusion injury signal pathway by flavonoid monomer].
Hu YQ; Liu JH
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):879-889. PubMed ID: 36872258
[TBL] [Abstract][Full Text] [Related]
7. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
9. Treatment of nephrotic syndrome: going beyond immunosuppressive therapy.
Zhao J; Liu Z
Pediatr Nephrol; 2020 Apr; 35(4):569-579. PubMed ID: 30904930
[TBL] [Abstract][Full Text] [Related]
10.
Bierzynska A; Soderquest K; Dean P; Colby E; Rollason R; Jones C; Inward CD; McCarthy HJ; Simpson MA; Lord GM; Williams M; Welsh GI; Koziell AB; Saleem MA; ;
J Am Soc Nephrol; 2017 May; 28(5):1614-1621. PubMed ID: 27932480
[TBL] [Abstract][Full Text] [Related]
11. Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.
Wu JB; Ye SF; Liang CL; Li YC; Yu YJ; Lai JM; Lin H; Zheng J; Zhou JY
J Ethnopharmacol; 2014 Feb; 151(3):1124-1132. PubMed ID: 24389029
[TBL] [Abstract][Full Text] [Related]
12. Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway.
Chen J; Yuan S; Zhou J; Huang X; Wu W; Cao Y; Liu H; Hu Q; Li X; Guan X; Yin S; Jiang J; Zhou Y; Zhou J
Phytomedicine; 2022 Dec; 107():154477. PubMed ID: 36215790
[TBL] [Abstract][Full Text] [Related]
13. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption.
Ashraf S; Gee HY; Woerner S; Xie LX; Vega-Warner V; Lovric S; Fang H; Song X; Cattran DC; Avila-Casado C; Paterson AD; Nitschké P; Bole-Feysot C; Cochat P; Esteve-Rudd J; Haberberger B; Allen SJ; Zhou W; Airik R; Otto EA; Barua M; Al-Hamed MH; Kari JA; Evans J; Bierzynska A; Saleem MA; Böckenhauer D; Kleta R; El Desoky S; Hacihamdioglu DO; Gok F; Washburn J; Wiggins RC; Choi M; Lifton RP; Levy S; Han Z; Salviati L; Prokisch H; Williams DS; Pollak M; Clarke CF; Pei Y; Antignac C; Hildebrandt F
J Clin Invest; 2013 Dec; 123(12):5179-89. PubMed ID: 24270420
[TBL] [Abstract][Full Text] [Related]
14. Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa.
Williams AE; Esezobor CI; Lane BM; Gbadegesin RA
Pediatr Nephrol; 2023 Jul; 38(7):2003-2012. PubMed ID: 36459247
[TBL] [Abstract][Full Text] [Related]
15. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
[TBL] [Abstract][Full Text] [Related]
16. A small molecule screening to detect potential therapeutic targets in human podocytes.
Widmeier E; Tan W; Airik M; Hildebrandt F
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F157-F171. PubMed ID: 27760769
[TBL] [Abstract][Full Text] [Related]
17. The Genetics of Nephrotic Syndrome.
Rheault MN; Gbadegesin RA
J Pediatr Genet; 2016 Mar; 5(1):15-24. PubMed ID: 27617138
[TBL] [Abstract][Full Text] [Related]
18. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
[TBL] [Abstract][Full Text] [Related]
19. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of procyanidin B2 on adriamycin-induced nephrotic syndrome mice: the multi-action mechanism for ameliorating glomerular permselectivity injury.
Zhao C; Tang J; Li X; Yan Z; Zhao L; Lang W; Yuan C; Zhou C
Food Funct; 2022 Aug; 13(16):8436-8464. PubMed ID: 35861207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]